Modified bacteria could fight this brain-damaging genetic disease

Modified bacteria could fight this brain-damaging genetic disease

Cambridge-based biotech Synlogic’s bacteria-based treatment for phenylketonuria (PKU) has shown positive results in a small phase 2 trial, the company announced in October – proof of concept for the idea of ​​using modified strains of beneficial bacteria to treat disease. “Diseases like PKU are good fruit at hand to answer the first question, which is …

Modified bacteria could fight this brain-damaging genetic disease Read More »